0001415889-24-005352.txt : 20240226
0001415889-24-005352.hdr.sgml : 20240226
20240226205748
ACCESSION NUMBER: 0001415889-24-005352
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240222
FILED AS OF DATE: 20240226
DATE AS OF CHANGE: 20240226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DIORIO CHRIS PH.D.
CENTRAL INDEX KEY: 0001677721
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37824
FILM NUMBER: 24681540
MAIL ADDRESS:
STREET 1: 400 FAIRVIEW AVENUE NORTH
STREET 2: SUITE 1200
CITY: SEATTLE
STATE: WA
ZIP: 98109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMPINJ INC
CENTRAL INDEX KEY: 0001114995
STANDARD INDUSTRIAL CLASSIFICATION: ELECTRONIC COMPONENTS, NEC [3679]
ORGANIZATION NAME: 04 Manufacturing
IRS NUMBER: 912041398
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 FAIRVIEW AVENUE NORTH
STREET 2: SUITE 1200
CITY: SEATTLE
STATE: WA
ZIP: 98109
BUSINESS PHONE: 206-517-5300
MAIL ADDRESS:
STREET 1: 400 FAIRVIEW AVENUE NORTH
STREET 2: SUITE 1200
CITY: SEATTLE
STATE: WA
ZIP: 98109
4
1
form4-02272024_010229.xml
X0508
4
2024-02-22
0001114995
IMPINJ INC
PI
0001677721
DIORIO CHRIS PH.D.
400 FAIRVIEW AVENUE NORTH
SUITE 1200
SEATTLE
WA
98109
true
true
false
false
CHIEF EXECUTIVE OFFICER
1
Common Stock
2024-02-22
4
A
0
25000
0
A
278738
D
Common Stock
2024-02-22
4
A
0
16185
0
A
294923
D
Common Stock
2024-02-23
4
S
0
8187
100.4910
D
286736
D
Common Stock
2024-02-23
4
S
0
7569
101.8305
D
279167
D
Common Stock
2024-02-23
4
S
0
304
102.4945
D
278863
D
Common Stock
2024-02-26
4
A
0
5000
21.81
A
283863
D
Common Stock
2024-02-26
4
S
0
5000
105
D
278863
D
Common Stock
572494
I
by DFT L.L.C.
Stock Option (right to buy)
21.81
2024-02-26
4
M
0
5000
0
D
2026-08-23
Common Stock
5000
31661
D
On April 12, 2021, the Reporting Person was granted performance restricted stock units (PSUs). The PSUs vested upon the Reporting Person's satisfaction of certain performance criteria. On February 21, 2024, the Issuer's Board of Directors determined the level at which the corporate performance goals were attained, resulting in the vesting of 25,000 shares of Common Stock underlying the PSUs.
The amount of securities beneficially owned includes 427 shares acquired on February 20, 2024 under the Impinj, Inc. 2016 Employee Stock Purchase Plan, in a transaction exempt under Rule 16b-3(c) that is being voluntarily reported by the reporting person on this Form 4.
On March 23, 2022, the Reporting Person was granted performance restricted stock units (PSUs). The PSUs vested upon the Reporting Person's satisfaction of certain performance criteria. On February 21, 2024, the Issuer's Board of Directors determined the level at which the corporate performance goals were attained, resulting in the vesting of 16,185 shares of Common Stock underlying the PSUs.
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $100.23 to $101.16, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $101.31 to $102.30, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $102.33 to $102.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan effective on November 6, 2023.
The option became fully vested on August 23, 2020.
/s/ Yukio Morikubo, Attorney in fact for Chris Diorio
2024-02-26